Scientific Letters
Vol. 17 No. 1 (2025): Review Articles, Original Article, Scientific Letter, Case Reports Letter to the Editor
Elevated endogenous alveolar carbon monoxide concentration in patients with transfusion-dependent thalassemia and its relation to ineffective erythropoiesis
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: December 9, 2024
Accepted: May 23, 2025
Accepted: May 23, 2025
537
Views
393
Downloads
18
HTML
Authors
Blood transfusion is a principal treatment for thalassemia at present, but there is still an absence of effective examination to evaluate the efficacy of blood transfusion and judge the timing of blood transfusion. Carbon monoxide (CO) breath test is a non-invasive and rapid examination way that could dynamically monitor red blood cell destruction in patients with thalassemia. A total of 61 patients with transfusion-dependent thalassemia and 21 healthy controls were recruited in the study.
Downloads
Download data is not yet available.
Citations
How to Cite
“Elevated endogenous alveolar carbon monoxide concentration in patients with transfusion-dependent thalassemia and its relation to ineffective erythropoiesis” (2025) Mediterranean Journal of Hematology and Infectious Diseases, 17(1), p. e2025047. doi:10.4084/MJHID.2025.047.
Copyright (c) 2025 yanni xie
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
